| Anaphylaxis: guidelines from the E uropean A cademy of A llergy and C linical I mmunology A Muraro, G Roberts, M Worm, MB Bilò, K Brockow, M Fernández Rivas, ... Allergy 69 (8), 1026-1045, 2014 | 1287 | 2014 |
| World allergy organization guidelines for the assessment and management of anaphylaxis FER Simons, LRF Ardusso, MB Bilò, YM El-Gamal, DK Ledford, J Ring, ... World Allergy Organization Journal 4 (2), 13-37, 2011 | 1178 | 2011 |
| EAACI molecular allergology user's guide PM Matricardi, J Kleine‐Tebbe, HJ Hoffmann, R Valenta, C Hilger, ... Pediatric Allergy and Immunology 27, 1-250, 2016 | 1014 | 2016 |
| Skin test concentrations for systemically administered drugs–an ENDA/EAACI Drug Allergy Interest Group position paper K Brockow, LH Garvey, W Aberer, M Atanaskovic‐Markovic, A Barbaud, ... Allergy 68 (6), 702-712, 2013 | 961 | 2013 |
| World Allergy Organization anaphylaxis guidelines: summary FER Simons, LRF Ardusso, MB Bilò, YM El-Gamal, DK Ledford, J Ring, ... Journal of Allergy and Clinical Immunology 127 (3), 587-593. e22, 2011 | 624 | 2011 |
| Anaphylaxis in children and adolescents: the European Anaphylaxis Registry LB Grabenhenrich, S Dölle, A Moneret-Vautrin, A Köhli, L Lange, ... Journal of allergy and clinical immunology 137 (4), 1128-1137. e1, 2016 | 607 | 2016 |
| International consensus on (ICON) anaphylaxis FER Simons, LRF Ardusso, MB Bilò, V Cardona, M Ebisawa, ... World Allergy Organization Journal 7, 9, 2014 | 542 | 2014 |
| The epidemiology of anaphylaxis in Europe: a systematic review SS Panesar, S Javad, D De Silva, BI Nwaru, L Hickstein, A Muraro, ... Allergy 68 (11), 1353-1361, 2013 | 515 | 2013 |
| Predictors of severe systemic anaphylactic reactions in patients with Hymenoptera venom allergy: importance of baseline serum tryptase—a study of the European Academy of … F Ruëff, B Przybilla, MB Biló, U Müller, F Scheipl, W Aberer, J Birnbaum, ... Journal of Allergy and Clinical Immunology 124 (5), 1047-1054, 2009 | 503 | 2009 |
| EAACI guidelines on allergen immunotherapy: Hymenoptera venom allergy GJ Sturm, EM Varga, G Roberts, H Mosbech, MB Bilò, CA Akdis, ... Allergy 73 (4), 744-764, 2018 | 440 | 2018 |
| 2012 Update: World Allergy Organization Guidelines for the assessment and management of anaphylaxis FER Simons, LRF Ardusso, MB Bilo, V Dimov, M Ebisawa, YM El-Gamal, ... Current opinion in allergy and clinical immunology 12 (4), 389-399, 2012 | 386 | 2012 |
| First European data from the network of severe allergic reactions (NORA) M Worm, A Moneret‐Vautrin, K Scherer, R Lang, M Fernandez‐Rivas, ... Allergy 69 (10), 1397-1404, 2014 | 348 | 2014 |
| Clinical contraindications to allergen immunotherapy: an EAACI position paper C Pitsios, P Demoly, MB Bilò, R Gerth van Wijk, O Pfaar, GJ Sturm, ... Allergy 70 (8), 897-909, 2015 | 311 | 2015 |
| EAACI guidelines: Anaphylaxis (2021 update) A Muraro, M Worm, C Alviani, V Cardona, A DunnGalvin, LH Garvey, ... Allergy 77 (2), 357-377, 2022 | 296 | 2022 |
| The natural history and epidemiology of insect venom allergy: clinical implications MB Bilo, F Bonifazi Clinical & Experimental Allergy 39 (10), 1467-1476, 2009 | 284 | 2009 |
| Epidemiology of Hymenoptera allergy L Antonicelli, MB Bilò, F Bonifazi Current opinion in allergy and clinical immunology 2 (4), 341-346, 2002 | 240 | 2002 |
| Factors increasing the risk for a severe reaction in anaphylaxis: An analysis of data from The European Anaphylaxis Registry M Worm, W Francuzik, JM Renaudin, MB Bilo, V Cardona, ... Allergy 73 (6), 1322-1330, 2018 | 223 | 2018 |
| Predictors of side effects during the buildup phase of venom immunotherapy for Hymenoptera venom allergy: the importance of baseline serum tryptase F Ruëff, B Przybilla, MB Biló, U Müller, F Scheipl, W Aberer, J Birnbaum, ... Journal of Allergy and Clinical Immunology 126 (1), 105-111. e5, 2010 | 206 | 2010 |
| Management of anaphylaxis: a systematic review S Dhami, SS Panesar, G Roberts, A Muraro, M Worm, MB Bilò, V Cardona, ... Allergy 69 (2), 168-175, 2014 | 183 | 2014 |
| Allergen-specific immunotherapy provides immediate, long-term and preventive clinical effects in children and adults: the effects of immunotherapy can be categorised by level … L Jacobsen, U Wahn, MB Bilo Clinical and translational allergy 2, 1-11, 2012 | 175 | 2012 |
